A phase 3 result would likely —seriously—be delivered in 2024/5 if they started the trial promptly, within 3 months of topline data. Think about that timeline and honestly assess whether Covid is a nuisance in 2025. The company stopped at some point for god knows what reason talking about their antiviral platform potential and no military alpha Bunyan beta yellow fever talk since. So…you’re left with the reality that the Covid landscape is intense with other drugs far ahead of little Ipix.
They need to sell the company or license drugs within 45 days of topline. Good thing they have hired locust walk or as lemon cat calls them “those morons”
News 
Market Data 
Discover 
